ArticleBMJ neurology open2025
Ten years of endovascular thrombectomy in northern New Zealand.
Article in BMJ neurology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In 2015, pivotal trials demonstrated that endovascular thrombectomy (EVT) in patients who had a large vessel occlusion stroke improves functional outcome. We report 10-year trends and outcomes from our centre, which provides EVT to 2.8 million people in northern New Zealand. Methods: We performed an audit of all patients who underwent EVT between 1 March 2015 and 1 March 2025 using the compulsory National Stroke Reperfusion Therapy Registry. Baseline characteristics, treatment variables and 3-month outcomes were analysed. Functional independence was defined as a modified Rankin scale score of 0-2. Results: 2184 patients were treated with EVT (48% women; mean age 67.6 years), with the number of treated patients increasing year-on-year. 1404 (63.8%) required interhospital transfer (638 (29.2%) via air ambulance). 1868 (85.5%) had successful reperfusion (Thrombolysis in Cerebral Infarction 2b-3). 1015 (46.5%) received intravenous thrombolysis. At day 90, 1095 (51.9%) patients were functionally independent, 1506 (72.8%) were living at home and 327 (15.5%) had died. Conclusion: EVT outcomes in New Zealand align with international results despite supra-regional logistical challenges. The growing number of treated cases reflects improved access to EVT across different regions and an expansion of eligibility criteria. Our study supports the continued development and provision of large hub-and-spoke EVT services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.